Incyte Shares Outstanding 2006-2018 | INCY

Current and historical number of shares outstanding for Incyte (INCY) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Incyte Annual Shares Outstanding
(Millions of US $)
2017 $205
2016 $194
2015 $187
2014 $168
2013 $148
2012 $130
2011 $125
2010 $122
2009 $103
2008 $90
2007 $84
2006 $84
2005 $83
Incyte Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $215
Q1 2018 $212
Q4 2017 $205
Q3 2017 $213
Q2 2017 $205
Q1 2017 $195
Q4 2016 $194
Q3 2016 $194
Q2 2016 $193
Q1 2016 $193
Q4 2015 $187
Q3 2015 $181
Q2 2015 $186
Q1 2015 $172
Q4 2014 $168
Q3 2014 $189
Q2 2014 $168
Q1 2014 $165
Q4 2013 $148
Q3 2013 $155
Q2 2013 $142
Q1 2013 $134
Q4 2012 $130
Q3 2012 $131
Q2 2012 $138
Q1 2012 $127
Q4 2011 $125
Q3 2011 $126
Q2 2011 $125
Q1 2011 $123
Q4 2010 $122
Q3 2010 $122
Q2 2010 $128
Q1 2010 $120
Q4 2009 $103
Q3 2009 $98
Q2 2009 $98
Q1 2009 $97
Q4 2008 $90
Q3 2008 $92
Q2 2008 $85
Q1 2008 $85
Q4 2007 $84
Q3 2007 $84
Q2 2007 $84
Q1 2007 $84
Q4 2006 $84
Q3 2006 $84
Q2 2006 $84
Q1 2006 $84
Q4 2005 $83
Q3 2005 $83
Q2 2005 $83
Q1 2005 $83
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.625B $1.536B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $127.784B 14.67
Gilead Sciences (GILD) United States $94.529B 10.49
Biogen (BIIB) United States $69.542B 14.74
Celgene (CELG) United States $63.563B 12.69
Illumina (ILMN) United States $47.904B 60.01
Vertex Pharmaceuticals (VRTX) United States $44.999B 102.37
Regeneron Pharmaceuticals (REGN) United States $40.441B 22.74
Alexion Pharmaceuticals (ALXN) United States $25.852B 19.43
BioMarin Pharmaceutical (BMRN) United States $17.938B 0.00
Seattle Genetics (SGEN) United States $11.852B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.521B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.457B 60.73
Sarepta Therapeutics (SRPT) United States $8.654B 0.00
Bluebird Bio (BLUE) United States $8.557B 0.00
QIAGEN (QGEN) Netherlands $8.509B 27.82
BeiGene (BGNE) Cayman Islands $8.458B 0.00
Alkermes (ALKS) Ireland $6.916B 0.00
Bio-Techne Corp (TECH) United States $6.782B 45.58
Exact Sciences (EXAS) United States $5.995B 0.00
Exelixis (EXEL) United States $5.722B 18.64
Ligand Pharmaceuticals (LGND) United States $5.233B 46.35
Galapagos (GLPG) Belgium $5.192B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.919B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.564B 0.00
Immunomedics (IMMU) United States $3.514B 0.00
Horizon Pharma Public (HZNP) Ireland $3.428B 19.41
Akcea Therapeutics (AKCA) United States $3.076B 0.00
Blueprint Medicines (BPMC) United States $3.059B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.058B 0.00
China Biologic Products (CBPO) China $3.048B 20.13
Array BioPharma (ARRY) United States $2.984B 0.00
Ascendis Pharma (ASND) Denmark $2.970B 0.00
Emergent Biosolutions (EBS) United States $2.965B 23.61
Myriad Genetics (MYGN) United States $2.952B 35.31
Medicines (MDCO) United States $2.941B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.733B 0.00
Global Blood Therapeutics (GBT) United States $2.566B 0.00
Amicus Therapeutics (FOLD) United States $2.500B 0.00
Halozyme Therapeutics (HALO) United States $2.478B 33.02
CRISPR THERAPTC (CRSP) Switzerland $2.316B 0.00
Spark Therapeutics (ONCE) United States $2.306B 0.00
MyoKardia (MYOK) United States $2.267B 0.00
Acceleron Pharma (XLRN) United States $2.226B 0.00
Repligen (RGEN) United States $2.169B 72.82
Momenta Pharmaceuticals (MNTA) United States $2.161B 0.00
Reata Pharmaceuticals (RETA) United States $2.141B 0.00
REGENXBIO (RGNX) United States $2.131B 33.48
Cambrex (CBM) United States $2.110B 16.92
AnaptysBio (ANAB) United States $2.070B 0.00
Genomic Health (GHDX) United States $1.965B 109.58
Mirati Therapeutics (MRTX) United States $1.940B 0.00
G1 THERAPEUTICS (GTHX) United States $1.918B 0.00
Clovis Oncology (CLVS) United States $1.856B 0.00
Arena Pharmaceuticals (ARNA) United States $1.764B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.715B 0.00
Rubius Therapeutics (RUBY) United States $1.647B 0.00
Aimmune Therapeutics (AIMT) United States $1.636B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.629B 0.00
Atara Biotherapeutics (ATRA) United States $1.628B 0.00
Insmed (INSM) United States $1.617B 0.00
Puma Biotechnology (PBYI) United States $1.593B 0.00
Allakos (ALLK) United States $1.575B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Denali Therapeutics (DNLI) United States $1.492B 0.00
Myovant Sciences (MYOV) United Kingdom $1.433B 0.00
Innoviva (INVA) United States $1.425B 9.14
Lion Biotechnologies (IOVA) United States $1.424B 0.00
Editas Medicine (EDIT) United States $1.424B 0.00
Solid Biosciences (SLDB) United States $1.403B 0.00
BIOHAVEN PHARM (BHVN) United States $1.399B 0.00
IMMURON LTD (IMRN) Australia $1.379B 0.00
WAVE Life Sciences (WVE) Singapore $1.372B 0.00
UniQure (QURE) Netherlands $1.352B 0.00
Acorda Therapeutics (ACOR) United States $1.339B 27.92
Deciphera Pharmaceuticals (DCPH) United States $1.316B 0.00
Coherus BioSciences (CHRS) United States $1.289B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.269B 0.00
Audentes Therapeutics (BOLD) United States $1.233B 0.00
Intellia Therapeutics (NTLA) United States $1.204B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.188B 0.00
Cellectis (CLLS) France $1.177B 0.00
Retrophin (RTRX) United States $1.152B 0.00
Athenex (ATNX) United States $1.147B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.144B 2185.00
Zai Lab Unsponsored ADR (ZLAB) China $1.122B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.100B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.084B 0.00
DBV Technologies (DBVT) France $1.072B 0.00
Intra-Cellular Therapies (ITCI) United States $1.044B 0.00
NeoGenomics (NEO) United States $1.034B 181.00
CytomX Therapeutics (CTMX) United States $1.011B 0.00
Apellis Pharmaceuticals (APLS) United States $0.983B 0.00
Revance Therapeutics (RVNC) United States $0.968B 0.00
AVROBIO (AVRO) United States $0.957B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.798B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.794B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.793B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.790B 0.00
Dynavax Technologies (DVAX) United States $0.789B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.788B 0.00
Aptinyx (APTX) United States $0.764B 0.00
Heska (HSKA) United States $0.753B 64.78
Cara Therapeutics (CARA) United States $0.743B 0.00
Epizyme (EPZM) United States $0.733B 0.00
Geron (GERN) United States $0.720B 0.00
InflaRx (IFRX) Germany $0.706B 0.00
Kura Oncology (KURA) United States $0.701B 0.00
UNITY Biotechnology (UBX) $0.670B 0.00
ANI Pharmaceuticals (ANIP) United States $0.667B 13.21
Eidos Therapeutics (EIDX) United States $0.667B 0.00
Abeona Therapeutics (ABEO) United States $0.635B 0.00
Viking Therapeutics (VKTX) United States $0.634B 0.00
Sorrento Therapeutics (SRNE) United States $0.625B 0.00
Anika Therapeutics (ANIK) United States $0.614B 25.83
Verastem (VSTM) United States $0.609B 0.00
Fate Therapeutics (FATE) United States $0.598B 0.00
Mesoblast (MESO) Australia $0.593B 0.00
UROGEN PHARMA (URGN) Israel $0.591B 0.00
Arcus Biosciences (RCUS) United States $0.590B 0.00
Prothena (PRTA) Ireland $0.578B 0.00
AC Immune SA (ACIU) Switzerland $0.564B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.559B 0.00
Replimune (REPL) United States $0.538B 0.00
Arbutus Biopharma (ABUS) Canada $0.504B 0.00
Kindred Biosciences (KIN) United States $0.487B 0.00
Novavax (NVAX) United States $0.478B 0.00
Vericel (VCEL) United States $0.474B 0.00
Stemline Therapeutics (STML) United States $0.469B 0.00
Five Prime Therapeutics (FPRX) United States $0.469B 0.00
Magenta Therapeutics (MGTA) United States $0.455B 0.00
Aduro Biotech (ADRO) United States $0.455B 0.00
Zymeworks (ZYME) Canada $0.453B 0.00
GTx (GTXI) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.438B 0.00
ObsEva SA (OBSV) Switzerland $0.436B 0.00
Zealand Pharma (ZEAL) Denmark $0.434B 0.00
Merus (MRUS) Netherlands $0.432B 0.00
MiMedx (MDXG) United States $0.432B 18.52
Senesco Technologies (ELOX) United States $0.417B 0.00
Unum Therapeutics (UMRX) United States $0.409B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.407B 0.00
Inovio Pharmaceuticals (INO) United States $0.405B 0.00
Evelo Biosciences (EVLO) United States $0.395B 0.00
Cytokineticsorporated (CYTK) United States $0.393B 0.00
Vital Therapies (VTL) United States $0.381B 0.00
MediciNova (MNOV) United States $0.381B 0.00
Scholar Rock Holding (SRRK) United States $0.379B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.369B 0.00
Sinovac Biotech (SVA) China $0.368B 0.00
Albireo Pharma (ALBO) United States $0.361B 0.00
Syros Pharmaceuticals (SYRS) United States $0.353B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.351B 0.00
RA PHARMCTL INC (RARX) United States $0.341B 0.00
PDL BioPharma (PDLI) United States $0.339B 4.76
Seres Therapeutics (MCRB) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.326B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.324B 0.00
Kezar Life Sciences (KZR) United States $0.321B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.316B 0.00
BioTime (BTX) United States $0.311B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.310B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.307B 0.00
Kala Pharmaceuticals (KALA) United States $0.299B 0.00
ResTORbio (TORC) United States $0.298B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.296B 0.00
Osiris Therapeutics (OSIR) United States $0.296B 0.00
Selecta Biosciences (SELB) United States $0.284B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.278B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.277B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.275B 0.00
Celyad SA (CYAD) Belgium $0.275B 0.00
Athersys (ATHX) United States $0.269B 0.00
Constellation Pharmaceuticals (CNST) United States $0.269B 0.00
Kadmon Holdings (KDMN) United States $0.266B 0.00
Celcuity (CELC) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.260B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.253B 0.00
MeiraGTx Holdings (MGTX) United States $0.253B 0.00
NantKwest (NK) United States $0.252B 0.00
Axovant Sciences (AXON) United Kingdom $0.250B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
Strongbridge Biopharma (SBBP) United States $0.241B 0.00
Idera Pharmaceuticals (IDRA) United States $0.239B 0.00
Cohbar (CWBR) United States $0.238B 0.00
Liquidia Technologies (LQDA) United States $0.230B 0.00
Allena Pharmaceuticals (ALNA) United States $0.221B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.221B 0.00
Kamada (KMDA) Israel $0.219B 17.03
Clearside Biomedical (CLSD) United States $0.217B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Enzo Biochem (ENZ) United States $0.192B 0.00
Palatin Technologies (PTN) United States $0.191B 7.39
Agenus (AGEN) United States $0.189B 0.00
Protagonist Therapeutics (PTGX) United States $0.188B 0.00
Signal Genetics (MGEN) United States $0.185B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Menlo Therapeutics (MNLO) United States $0.177B 0.00
BioDelivery Sciences (BDSI) United States $0.170B 0.00
OVID THERAPEUTC (OVID) United States $0.169B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
Krystal Biotech (KRYS) United States $0.168B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Mustang Bio (MBIO) United States $0.168B 0.00
MannKind (MNKD) United States $0.164B 0.00
TOCAGEN INC (TOCA) United States $0.162B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.155B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.152B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
Pfenex (PFNX) United States $0.149B 0.00
XBiotech (XBIT) United States $0.149B 0.00
Organovo Holdings (ONVO) United States $0.143B 0.00
Pluristem Therapeutics (PSTI) Israel $0.140B 0.00
Intec Pharma (NTEC) Israel $0.133B 0.00
XOMA (XOMA) United States $0.133B 14.00
Cerecor (CERC) United States $0.132B 16.29
Motif Bio Plc (MTFB) United States $0.132B 0.00
Monster Digital (INNT) United States $0.131B 0.00
Provention Bio (PRVB) United States $0.130B 0.00
BioXcel Therapeutics (BTAI) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
Anavex Life Sciences (AVXL) United States $0.123B 0.00
Aptevo Therapeutics (APVO) United States $0.122B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
VBI Vaccines (VBIV) United States $0.121B 0.00
Cidara Therapeutics (CDTX) United States $0.120B 0.00
Trevena (TRVN) United States $0.119B 0.00
PSivida (EYPT) United States $0.108B 0.00
Tapimmune (TPIV) United States $0.107B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.106B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
NewLink Genetics (NLNK) United States $0.101B 0.00
Aptose Biosciences (APTO) Canada $0.100B 0.00
ScPharmaceuticals (SCPH) United States $0.100B 0.00
Orgenesis (ORGS) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.095B 0.00
Asterias Biotherapeutics (AST) United States $0.089B 0.00
Alcobra (ARCT) Israel $0.088B 0.00
Ophthotech (OPHT) United States $0.087B 0.56
Proteostasis Therapeutics (PTI) United States $0.086B 0.00
Eleven Biotherapeutics (SESN) United States $0.086B 0.00
OncoSec Medical (ONCS) United States $0.080B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.078B 0.00
Histogenics (HSGX) United States $0.076B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Sophiris Bio (SPHS) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.070B 0.00
Protalix BioTherapeutics (PLX) Israel $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.070B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
VIVUS (VVUS) United States $0.066B 0.00
Axsome Therapeutics (AXSM) United States $0.064B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
TRACON Pharmaceuticals (TCON) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Novelion Therapeutics (NVLN) Canada $0.057B 0.00
VolitionRX (VNRX) Singapore $0.056B 0.00
Neothetics (EVFM) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.053B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Chiasma (CHMA) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
Celsion (CLSN) United States $0.045B 0.00
CorMedix Inc (CRMD) United States $0.044B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
Proteon Therapeutics (PRTO) United States $0.043B 0.00
GENPREX INC (GNPX) United States $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
CytRx (CYTR) United States $0.037B 0.00
VTv Therapeutics (VTVT) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
BioPharmX (BPMX) United States $0.031B 0.00
AquaBounty Technologies (AQB) United States $0.031B 0.00
AEterna Zentaris (AEZS) United States $0.030B 60.67
Benitec Biopharma (BNTC) Australia $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Cel-Sci (CVM) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.027B 0.00
Arsanis (ASNS) United States $0.026B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Oncobiologics (ONS) United States $0.025B 0.00
Gemphire Therapeutics (GEMP) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
RestorGenex (DFFN) United States $0.020B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
AmpliPhi Biosciences (APHB) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.013B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 6.16
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Galena Biopharma (SLS) United States $0.007B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00